| Quarter (USD) | Mar 23 | Mar 22 | Mar 21 | Mar 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Mar 23 | Mar 22 | Mar 21 | Mar 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| 13F holders | Current |
|---|---|
| Total holders | 17 |
| Opened positions | 6 |
| Closed positions | 82 |
| Increased positions | 4 |
| Reduced positions | 2 |
| 13F shares | Current |
|---|---|
| Total value | 717.58 mm |
| Total shares | 30.18 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Sun Pharmaceutical Industries | 29.50 mm | $0.00 |
| Krensavage Asset Management | 650.09 k | $27.95 mm |
| Analyst IMS Investment Management Services | 13.56 k | $583.00 k |
| Rhumbline Advisers | 12.63 k | $542.49 mm |
| LRI Investments | 2.00 k | $85.78 mm |
| Gladius Capital Management | 761.00 | $32.70 mm |
| Advisor | 199.00 | $8.55 mm |
| Lindbrook Capital | 142.00 | $6.10 mm |
| Farther Finance Advisors | 126.00 | $5.41 mm |
| Cornerstone Planning | 94.00 | $0.00 |
